Amylyx Pharmaceuticals, Inc. (AMLX)
28.14
+0.94
(+3.46%)
USD |
NASDAQ |
Oct 09, 16:00
28.15
+0.01
(+0.04%)
After-Hours: 20:00
Amylyx Pharmaceuticals 30-Day Average Daily Volume : 1.536M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.536M |
| October 08, 2026 | 1.553M |
| October 07, 2026 | 1.559M |
| October 06, 2026 | 1.562M |
| October 05, 2026 | 1.644M |
| October 02, 2026 | 1.767M |
| October 01, 2026 | 2.021M |
| September 30, 2026 | 2.252M |
| September 29, 2026 | 3.007M |
| September 28, 2026 | 3.010M |
| September 25, 2026 | 3.029M |
| September 24, 2026 | 3.014M |
| September 23, 2026 | 3.015M |
| September 22, 2026 | 2.982M |
| September 21, 2026 | 2.980M |
| September 18, 2026 | 3.036M |
| September 17, 2026 | 3.086M |
| September 16, 2026 | 3.092M |
| September 15, 2026 | 3.161M |
| September 14, 2026 | 3.156M |
| September 11, 2026 | 3.153M |
| September 10, 2026 | 3.214M |
| September 09, 2026 | 3.224M |
| September 08, 2026 | 3.295M |
| September 04, 2026 | 3.342M |
| Date | Value |
|---|---|
| September 03, 2026 | 3.367M |
| September 02, 2026 | 3.342M |
| September 01, 2026 | 3.329M |
| August 31, 2026 | 3.359M |
| August 28, 2026 | 3.316M |
| August 27, 2026 | 3.312M |
| August 26, 2026 | 3.277M |
| August 25, 2026 | 3.218M |
| August 24, 2026 | 3.213M |
| August 21, 2026 | 3.138M |
| August 20, 2026 | 3.019M |
| August 19, 2026 | 2.766M |
| August 18, 2026 | 2.521M |
| August 17, 2026 | 1.772M |
| August 14, 2026 | 1.776M |
| August 13, 2026 | 1.770M |
| August 12, 2026 | 1.802M |
| August 11, 2026 | 1.849M |
| August 10, 2026 | 1.902M |
| August 07, 2026 | 1.976M |
| August 06, 2026 | 2.004M |
| August 05, 2026 | 1.937M |
| August 04, 2026 | 1.939M |
| August 03, 2026 | 1.871M |
| July 31, 2026 | 1.858M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Pfizer Inc. | 32.85M |
| Eli Lilly & Co. | 2.303M |
| Merck & Co., Inc. | 9.427M |
| Bristol Myers Squibb Co. | 11.39M |
| ANI Pharmaceuticals, Inc. | 406914.5 |